Bracco and Aenitis Partner on Acoustic Beads for Cell Sorting This strategic partnership is set to explore the development of next-generation acoustic microspheres, a groundbreaking alternative to conventional magnetic beads for rare and complex cell sorting and separation in flow-based applications.

Get in touch You might have questions regarding our products or activities. Rest assured, your inquiries matter. No matter the weather. Fill out the form below and submit your message.

Bracco Imaging Receives FDA Fast Track Designation for BR55 Bracco Imaging announced today that the U.S. FDA has granted Fast Track designation for the development of BR55 (perfluorobutane/nitrogen lipopeptide-coated microbubbles) injection for detecting areas of active bowel inflammation in patients with Crohn's disease.

PGP key

Bracco Diagnostics Inc.’s Coordinated Vulnerability Disclosure Program The Coordinated Vulnerability Disclosure Program applies to all commercially available Bracco Diagnostics Inc. software-enabled products. This program is designed as a resource for security researchers to report security vulnerabilities to Bracco Diagnostics Inc.

Bracco’s HeartSee: New Features for CAD Diagnosis and Ease of Use Bracco Diagnostics Inc. announced today significant upgrades to its innovative HeartSeeTM software, a leading diagnostic tool used in myocardial blood flow (MBF) quantification with cardiac positron emission tomography (PET) imaging.

The Bracco Foundation: A culture based on values The origins of the Bracco Foundation lie in the heritage of values passed down for nearly a century from the Bracco family and the Bracco Group, fostering a sense of Corporate Social Responsibility. The Foundation aims to create and spread expressions of culture, art, and science as means for improving our quality of life. It pays specific attention to women and younger generations, encouraging social cohesion.

New Nationwide Real-World Data Validates the Safety of LUMASON® UEA in Contemporary Echocardiographic Practice Bracco Diagnostics Inc. announced today that the results of a nationwide real-world study, published by Dr. Strom et al. in the Journal of the American Heart Association on 14 May 2025, provide valuable information on safety outcomes of cardiac ultrasound procedures in contemporary practice in the United States.